Anti-EPM2A Antibody [P3F3AT] (A58343)

Anti-EPM2A Antibody [P3F3AT]

Mouse monoclonal (P3F3AT) antibody to EPM2A

EPM2A antibody has been tested by ELISA and Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Recommended dilution range for Western blot analysis is 1:1,000 ~ 2,000. Recommended starting dilution is 1:1,000.

Anti-human EPM2A mAb, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with recombinant human EPM2A amino acids 243-331 purified from E. coli.

Mouse

Monoclonal

P3F3AT

IgG1

EPM2A antibody was purified from mouse ascitic fluids by protein-G affinity chromatography.

1mg/ml containing PBS, pH-7.4, & 0.1% Sodium Azide.

Epilepsy progressive myoclonus type 2 Lafora disease (laforin), Epilepsy progressive myoclonus type 2A Lafora disease (laforin), EPM2, Epm2a gene, EPM2A_HUMAN, Lafora PTPase, Laforin, LAFPTPase, LD, LDE, MELF, RP3-466P17.2